iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling 3,799 shares, a decline of 40.0% from the January 15th total of 6,335 shares. Approximately 1.2% of the company’s shares are sold short. Based on an average daily volume of 11,722 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 11,722 shares, the short-interest ratio is currently 0.3 days. Approximately 1.2% of the company’s shares are sold short.

iShares Health Innovation Active ETF Price Performance

NYSEARCA:BMED traded up $0.13 during mid-day trading on Friday, hitting $30.48. 1,533 shares of the company’s stock were exchanged, compared to its average volume of 7,568. iShares Health Innovation Active ETF has a one year low of $20.57 and a one year high of $32.19. The company has a market cap of $9.75 million, a PE ratio of 24.91 and a beta of 0.84. The business has a fifty day moving average price of $30.84 and a 200 day moving average price of $28.56.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.